We are live on ! Find out more
Primecap Management

Primecap Management Portfolio holdings

AUM $169B Turnover 4.85%
1-Year Est. Return 114.72%
This Fund
S&P 500
This Quarter Est. Return
+8.4%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$149B
AUM Growth
+$5.43B
Cap. Flow
-$4.27B
Cap. Flow %
-2.87%
Top 10 Hldgs %
30.32%
Holding
338
New
11
Increased
51
Reduced
229
Closed
5
Avg Time Held
4.7 years
Top 10 Avg Time Held
5 years
Top 20 Avg Time Held
4.3 years

Top Buys

Rank Stock Value
1
SPLK icon
Splunk Inc
SPLK
+$151M
2
BABA icon
Alibaba
BABA
+$115M
3
XPEV icon
XPeng
XPEV
+$79M
4
RJF icon
Raymond James Financial
RJF
+$71.4M
5
ALLO icon
Allogene Therapeutics
ALLO
+$64.8M

Sector Composition

Rank Sector Weight
1 Technology 30.47%
2 Healthcare 26.99%
3 Industrials 12.32%
4 Consumer Discretionary 10.96%
5 Financials 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LLY icon
1
Eli Lilly
LLY
$1.12T
$7.79B 5.24%
33,959,267
-1,418,968
-4% -$285M
2013 Q2
32 quarters
BIIB icon
2
Biogen
BIIB
$34.8B
$5.7B 3.83%
16,458,506
-299,750
-2% -$90.8M
2013 Q2
32 quarters
MSFT icon
3
Microsoft
MSFT
$4.01T
$5.06B 3.4%
18,675,549
-742,145
-4% -$189M
2013 Q2
32 quarters
ADBE icon
4
Adobe
ADBE
$97.9B
$4.29B 2.88%
7,323,998
-389,235
-5% -$201M
2013 Q2
32 quarters
FDX icon
5
FedEx
FDX
$69.9B
$4.12B 2.76%
13,794,161
-142,548
-1% -$42.3M
2013 Q2
32 quarters
AMGN icon
6
Amgen
AMGN
$235B
$3.96B 2.66%
16,249,072
-425,500
-3% -$105M
2013 Q2
32 quarters
TXN icon
7
Texas Instruments
TXN
$255B
$3.79B 2.55%
19,703,319
-879,834
-4% -$165M
2013 Q2
32 quarters
MU icon
8
Micron Technology
MU
$1.05T
$3.71B 2.49%
43,652,263
-1,776,326
-4% -$150M
2013 Q2
32 quarters
BABA icon
9
Alibaba
BABA
$276B
$3.55B 2.38%
15,635,272
+518,556
+3% +$115M
2014 Q3
27 quarters
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.27T
$3.17B 2.13%
25,975,980
-1,881,180
-7% -$220M
2015 Q3
23 quarters
LUV icon
11
Southwest Airlines
LUV
$20B
$3B 2.02%
56,511,976
-2,464,294
-4% -$148M
2013 Q2
32 quarters
AZN icon
12
AstraZeneca
AZN
$259B
$2.92B 1.96%
24,352,097
-604,516
-2% -$66.3M
2015 Q3
23 quarters
TSLA icon
13
Tesla
TSLA
$1.43T
$2.76B 1.85%
12,184,395
-216,645
-2% -$47M
2013 Q2
32 quarters
SONY icon
14
Sony
SONY
$144B
$2.74B 1.84%
140,956,025
-2,881,320
-2% -$58.4M
2013 Q2
32 quarters
KLAC icon
15
KLA
KLAC
$228B
$2.63B 1.77%
81,059,840
-3,332,250
-4% -$107M
2013 Q2
32 quarters
WFC icon
16
Wells Fargo
WFC
$248B
$2.26B 1.52%
49,869,195
+153,935
+0.3% +$6.87M
2013 Q2
32 quarters
TMO icon
17
Thermo Fisher Scientific
TMO
$258B
$2.21B 1.48%
4,377,264
-109,910
-2% -$51.9M
2013 Q4
30 quarters
SCHW icon
18
Charles Schwab
SCHW
$163B
$2.12B 1.43%
29,171,839
-240,440
-0.8% -$17M
2013 Q2
32 quarters
GOOG icon
19
Alphabet (Google) Class C
GOOG
$4.22T
$2.12B 1.42%
16,895,400
-1,750,780
-9% -$209M
2013 Q2
32 quarters
JPM icon
20
JPMorgan Chase
JPM
$891B
$1.99B 1.34%
12,787,174
-660,781
-5% -$104M
2015 Q1
25 quarters
INTC icon
21
Intel
INTC
$504B
$1.96B 1.32%
34,918,555
+709,880
+2% +$41.7M
2013 Q2
32 quarters
BIDU icon
22
Baidu
BIDU
$28.1B
$1.94B 1.3%
9,495,285
+60,406
+0.6% +$12.1M
2019 Q4
6 quarters
NTAP icon
23
NetApp
NTAP
$42.2B
$1.87B 1.26%
22,884,731
-3,016,791
-12% -$236M
2013 Q2
32 quarters
NVS icon
24
Novartis
NVS
$286B
$1.76B 1.18%
19,281,850
-1,261,950
-6% -$112M
2013 Q2
32 quarters
BSX icon
25
Boston Scientific
BSX
$64B
$1.71B 1.15%
40,020,445
-991,895
-2% -$41.7M
2013 Q2
32 quarters

Similar funds

Primecap Management's Q2 2021 Portfolio in Review

As of Q2 2021, Primecap Management held 338 positions worth $149B, up 3.8% from $143B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q2 2021: portfolio turnover was 4.7%. Primecap Management opened 11 new positions and exited 5, leaving the 338-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.

  • Primecap Management's largest Q2 2021 buy was Xometry: 300,000 shares worth $26.2M.
  • Primecap Management added most to Splunk Inc in Q2 2021, an estimated $151M increase.
  • Primecap Management's biggest Q2 2021 reduction was Eli Lilly, cutting an estimated $285M.
  • Primecap Management fully exited Perspecta Inc. Common Stock in Q2 2021, selling an estimated $16.9M.
  • Primecap Management's ten largest holdings make up 30% of its $149B portfolio in Q2 2021.
  • Primecap Management opened 11 new positions and closed 5 in Q2 2021.
  • Primecap Management's portfolio value rose 3.8% quarter-over-quarter to $149B.

Based on Primecap Management's 13F filing for Q2 2021, filed 10 Aug 2021.